These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3316283)

  • 21. Serum immunoglobulin levels in patients with head and neck cancer (IgE, IgA, IgM, IgG).
    Vinzenz K; Pavelka R; Schönthal E; Zekert F
    Oncology; 1986; 43(5):316-22. PubMed ID: 3763126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum levels of interleukins 4 and 10 in head and neck squamous cell carcinoma.
    Mojtahedi Z; Khademi B; Yehya A; Talebi A; Fattahi MJ; Ghaderi A
    J Laryngol Otol; 2012 Feb; 126(2):175-9. PubMed ID: 21888745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum phosphohexose isomerase activities in patients with colorectal cancer.
    Filella X; Molina R; Jo J; Mas E; Ballesta AM
    Tumour Biol; 1991; 12(6):360-7. PubMed ID: 1798910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of serum markers in the diagnosis and management of laryngeal cancer.
    Mevio E; Benazzo M; Galioto P; Spriano P; Pizzala R
    Clin Otolaryngol Allied Sci; 1991 Feb; 16(1):90-2. PubMed ID: 2032368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1, TPS) in Head and Neck Cancer Patients.
    Barak V; Meirovitz A; Leibovici V; Rachmut J; Peretz T; Eliashar R; Gross M
    Anticancer Res; 2015 Oct; 35(10):5519-24. PubMed ID: 26408719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analytical and clinical evaluation of CYFRA 21-1 by electrochemiluminescent immunoassay in head and neck squamous cell carcinoma.
    Deng YF; Chen P; Lin YZ; Le JZ; Wu XL; Yu MQ; Zhuang PY; Gao MH
    J Laryngol Otol; 2003 Mar; 117(3):190-4. PubMed ID: 12648374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta 2-microglobulin in squamous cell carcinomas of the head and neck and in tumours heterotransplanted into nude athymic mice.
    Wennerberg J; Alm P; Lögdberg L; Tropé C
    Acta Otolaryngol; 1984; 98(3-4):335-42. PubMed ID: 6388230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum sialic acid levels in lung cancer patients.
    Krolikowski FJ; Reuter K; Waalkes TP; Sieber SM; Adamson RH
    Pharmacology; 1976; 14(1):47-51. PubMed ID: 183223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study of a new tumour marker, CYFRA 21-1, in squamous cell carcinoma of the head and neck, and comparison with squamous cell carcinoma antigen.
    Yen TC; Lin WY; Kao CH; Cheng KY; Wang SJ
    Clin Otolaryngol Allied Sci; 1998 Feb; 23(1):82-6. PubMed ID: 9563673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumour-derived plasma cell-free DNA in patients with head and neck cancer: A short review.
    Rave-Fränk M
    Cancer Radiother; 2017 Oct; 21(6-7):554-556. PubMed ID: 28847459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnostic value of E-cadherin, MMP-9, activated MMP-13 and anti-p53 antibodies in squamous cell carcinomas of head and neck].
    Al Kassam D; Alvarez Marcos C; Blanco I; de Los Toyos JR; Llorente JL
    Med Clin (Barc); 2007 Dec; 129(20):761-5. PubMed ID: 18093475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression signature in peripheral blood cells for molecular diagnosis of head and neck squamous cell carcinoma.
    Braakhuis BJ; Graveland AP; Dijk F; Ylstra B; van Wieringen WN; Leemans CR; Brakenhoff RH
    Oral Dis; 2013 Jul; 19(5):452-5. PubMed ID: 23034102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Serum Fucose Levels in Leukoplakia and Oral Cancer Patients.
    Rai NP; Anekar J; Shivaraja Shankara YM; Divakar DD; Al Kheraif AA; Ramakrishnaiah R; Sebastian R; Raj AC; Al-Hazmi A; Mustafa SM
    Asian Pac J Cancer Prev; 2015; 16(17):7497-500. PubMed ID: 26625751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical value of head and neck tumor markers].
    Gascón Vilaplana P
    Med Clin (Barc); 2007 Dec; 129(20):775-6. PubMed ID: 18093479
    [No Abstract]   [Full Text] [Related]  

  • 35. The usefulness of new serum tumor markers in head and neck squamous cell carcinoma.
    Marcos CA; Martínez DA; de Los Toyos JR; Domínguez Iglesias F; Hermsen M; Guervós MA; Pendás JL
    Otolaryngol Head Neck Surg; 2009 Mar; 140(3):375-80. PubMed ID: 19248946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycoprotein tumour markers in head and neck neoplasms--a consecutive study on CA-50, CA 19-9, and CEA.
    Gustafsson H; Franzén L; Grankvist K; Anniko M; Henriksson R
    J Cancer Res Clin Oncol; 1988; 114(4):394-8. PubMed ID: 3165978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Crystallization test in patients with head and neck neoplasms].
    Kuczkowski J; Zaorski P; Betlejewski A
    Otolaryngol Pol; 1995; 49 Suppl 20():121-4. PubMed ID: 9454116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic value of tumoral markers in serous effusions: carcinoembryonic antigen, alpha1-acidglycoprotein, alpha-fetoprotein, phosphohexose isomerase, and beta 2-microglobulin.
    Martinez-Vea A; Gatell JM; Segura F; Heiman C; Elena M; Ballesta AM; Mundo MR
    Cancer; 1982 Nov; 50(9):1783-8. PubMed ID: 6180821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association and prognostic value of serum inflammation markers in patients with leukoplakia and oral cavity cancer.
    Chang PY; Kuo YB; Wu TL; Liao CT; Sun YC; Yen TC; Chan EC
    Clin Chem Lab Med; 2013 Jun; 51(6):1291-300. PubMed ID: 23154424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Serum ferritin and beta-2-microglobulin in multiple myeloma].
    Linkesch W; Ludwig H
    Acta Med Austriaca; 1982; 9(5-6):227-31. PubMed ID: 6187172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.